Image For Activity Cover
Management of Hypertrophic Cardiomyopathy: JACC State-Of-The-Art Review (JACC February 2022-1)

This article disusses management of hypertrophic cardiomyopathy and how contemporary treatments have effectively transformed HCM into a highly treatable condition with relatively low morbidity/mortality.


Valentin Fuster, MD, PhD, MACC

CME Editor
Ragavendra R. Baliga, MD

Barry J. Maron, MD

Important Dates

Date of Release: January 24, 2022
Term of Approval/Date of CME/MOC/ECME Expiration: January 23, 2023

Availability: On-Demand
Expires on Jan 23, 2024
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
1 ECME Credit
Android App Download IOS App Download Powered By